While the current study focuses on the role of Azeliragon in pancreatic cancer, the involvement of RAGE in other cancers, such as colorectal and lung cancer, suggests that Azeliragon could have broader therapeutic applications [14,47]. This evidence concerns the gene AGER and pancreatic neoplasm.